Amrutanjan Health Care Limited - Laporan Laba Rugi (TTM)

Amrutanjan Health Care Limited
IN ˙ NSEI
₹ 769.30 ↑37.85 (5.17%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Amrutanjan Health Care Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 2,811 2,984 3,330 3,644 3,829 3,935 4,059 3,986 3,990 3,860 3,798 3,865 3,753 3,946 4,214 4,271 4,378 4,436 4,520 4,623
Change (%) 6.17 11.59 9.44 5.06 2.77 3.17 -1.81 0.11 -3.27 -1.61 1.79 -2.92 5.16 6.78 1.36 2.52 1.32 1.88 2.28
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,212 1,251 1,432 1,527 1,672 1,739 1,838 1,816 1,892 1,843 1,874 1,876 1,900 2,046 2,170 2,152 2,239 2,231 2,289 2,343
Change (%) 3.29 14.40 6.63 9.53 4.00 5.71 -1.18 4.13 -2.57 1.69 0.10 1.27 7.70 6.06 -0.83 4.04 -0.35 2.59 2.35
% of Revenue 43.11 41.94 42.99 41.89 43.67 44.19 45.28 45.57 47.40 47.75 49.35 48.53 50.63 51.85 51.51 50.39 51.14 50.30 50.65 50.69
Gross Operating Profit 1,599 1,733 1,899 2,118 2,157 2,196 2,221 2,169 2,099 2,017 1,924 1,989 1,853 1,900 2,043 2,119 2,139 2,205 2,230 2,280
Change (%) 8.35 9.57 11.55 1.84 1.81 1.16 -2.34 -3.26 -3.90 -4.63 3.43 -6.87 2.54 7.56 3.69 0.97 3.05 1.17 2.21
% of Revenue 56.89 58.06 57.01 58.11 56.33 55.81 54.72 54.43 52.60 52.25 50.65 51.47 49.37 48.15 48.49 49.61 48.86 49.70 49.35 49.31
SG&A 777 763 497 966 1,159 1,211 505 1,037 494 500 493 973 461 398 484 1,048 537 593 597 605
Change (%) -1.83 -34.89 94.41 20.05 4.51 -58.30 105.27 -52.33 1.17 -1.45 97.43 -52.65 -13.50 21.54 116.46 -48.76 10.40 0.71 1.26
% of Revenue 27.65 25.56 14.92 26.50 30.28 30.79 12.44 26.01 12.39 12.96 12.98 25.17 12.28 10.10 11.49 24.55 12.27 13.37 13.21 13.08
R&D
Change (%)
% of Revenue
OpEx 2,282 2,302 2,612 2,864 3,094 3,209 3,261 3,343 3,383 3,391 3,379 3,439 3,390 3,492 3,741 3,852 3,877 3,918 3,987 4,041
Change (%) 0.91 13.46 9.63 8.02 3.72 1.64 2.50 1.20 0.25 -0.37 1.76 -1.41 3.01 7.13 2.95 0.67 1.05 1.76 1.34
% of Revenue 81.17 77.15 78.44 78.58 80.80 81.54 80.33 83.87 84.78 87.87 88.98 88.96 90.34 88.50 88.79 90.18 88.56 88.33 88.22 87.41
Operating Income 529 682 718 781 735 726 798 643 607 468 419 427 362 454 472 419 501 518 533 582
Change (%) 28.83 5.30 8.72 -5.81 -1.22 9.94 -19.45 -5.55 -22.89 -10.63 1.98 -15.10 25.26 4.08 -11.21 19.44 3.37 2.84 9.30
% of Revenue 18.83 22.85 21.56 21.42 19.20 18.46 19.67 16.13 15.22 12.13 11.02 11.04 9.66 11.50 11.21 9.82 11.44 11.67 11.78 12.59
Interest Expense -2 -2 -5 -5 -6 -6 -5 -4 -4 -4 -1 -1 -1 -1 -2 -2 -2 -2 -2 -2
Change (%) -1.82 143.90 8.00 4.43 -2.32 -12.04 -12.47 -11.70 -3.68 -78.62 -0.65 13.32 44.01 25.36 25.97 13.02 0.76 -2.49 -5.98
% of Revenue -0.07 -0.07 -0.15 -0.15 -0.15 -0.14 -0.12 -0.11 -0.09 -0.09 -0.02 -0.02 -0.02 -0.03 -0.04 -0.05 -0.05 -0.05 -0.05 -0.04
Net Income 474 589 612 668 631 627 672 588 517 418 398 432 373 440 450 426 475 493 508 545
Change (%) 24.27 3.97 9.20 -5.54 -0.65 7.14 -12.49 -12.05 -19.08 -4.81 8.41 -13.70 18.08 2.19 -5.33 11.62 3.78 3.08 7.27
% of Revenue 16.85 19.72 18.37 18.34 16.49 15.94 16.55 14.75 12.96 10.84 10.49 11.17 9.93 11.15 10.67 9.97 10.85 11.12 11.25 11.80

Source: Capital IQ

Other Listings
IN:590006
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista